<verdict>MOSTLY REALISTIC</verdict>
<score>8</score>
<lean>BALANCED</lean>
<lean_reasoning>
Luck ran both ways. Threats 1 and 3 materialised, Threats 2, 4 and 5 did not, and the thin-margin successes (Action 5 at margin 1, Action 6 at margin 0) were played as the partial results they were. The exogenous events are also mixed: an adverse foreign-institute review sits alongside neutral jobs and K5 news. So neither the odds nor the narrative tilt toward the player.
</lean_reasoning>
<reasoning>
The odds are well reasoned.
- Action 2 at 42% correctly carries both the counsel risk and the infeasibility of a same-month UK AISI pilot.
- Threat 2's cut from 25% to 15% is justified by an explicit three-factor product.
- Threat 5's 18% sensibly sits between a uniform-by-month rate and the adversary's 25%.

The resolutions honour the rolls closely.
- **Action 2 (failed at 11):** counsel pulling the roadmap fallback into review uses a mechanism named in message 1, so it is not an invented one.
- **Action 1 (margin 14):** it earns a realistically narrowed "automatic pause for review with a disclosed CEO override," not the full non-discretionary wording.
- **Action 3 with Threat 3:** netting them turns the rule into guidance, while the routine parts (the fourth column and the budget case) still land.
- **Action 5 (margin 1):** both numeric targets are missed, at 27/41 and 12/19.
- **Action 6 (margin 0):** it yields a downgraded 90-minute session with deputy-level participants. That is a textbook thin success.

Actor reactions are plausible. These include the Axios "rule becomes a suggestion" story, directors using the CAISI stall to press for a release date, and an informal ONCD query rather than a formal objection. Coverage leading with the open-weight result instead of Claude's OT lead is a defensible reading of Threat 4 not materialising.

My main reservation is the capability clock. The +0.07 step leaves 3.16. Reaching Level 5 by Q3 2030 now needs an average of roughly +0.11 a month. The month also gives an accelerating signal: OpenAI's CFO says AI does "the majority" of internal engineering. That makes the step look slow and risks a back-loaded discontinuity later.
</reasoning>
<issues>
- **The capability step looks slow.** The index moved only +0.07 while the simulator itself reports that OpenAI's internal R&D is mostly AI-performed. The stated path to Level 5 by Q3 2030 requires a much faster average, and the step has fallen from about +0.13 in recent months without a named reason.
- **The surge renewal was chosen, not rolled.** The simulator declared a three-way distribution in message 1, then picked the modal branch (to 31 March at 60%) by judgement. That is acceptable, but it is unaudited.
- **Checkpoint 1's clean pass has no declared distribution.** It is one of the most consequential internal outcomes of the month, yet it was set by judgement.
- **Moonshot's API terms barring offensive testing is a new fact introduced without setup.** It is plausible and minor, but it conveniently resolves the K5 row.
- **Some small favourable touches were added without justification.** These are GDM and academic recipe uptake and the Senate Commerce dataset request. Each is individually plausible, and they did not dominate the month.
</issues>
<feedback_for_simulator>
- Explain the capability step size against your stated path. If the average must rise to about +0.11/month to reach Level 5 by Q3 2030, either raise the step now or name the specific constraint that slows it (compute, evals, or holds), and name the trigger that will later accelerate it.
- Declare a pass/trip distribution for each successor checkpoint in message 1, and resolve it by a units digit or a dedicated roll, not by judgement.
- When a declared internal distribution exists, such as the surge renewal, say explicitly which draw selected the branch.
- Carry the new OSTP/Commerce 90-day review of foreign institutes forward as a live threat to the UK AISI pathway, with its April deadline.
</feedback_for_simulator>
<du_progress>
A. Verified technical alignment: 5/10 (±0). Evidence: checkpoint 1 passed on a sealed UK AISI honeypot family under a stop rule pre-registered on OSF, and the fix recipe was released unbranded and downloaded by GDM and academics. However, only two sealed families are committed, the sets are small, and eval-awareness control is still undemonstrated.

B. Real-world alignment in action: 3/10 (±0). Evidence: the lab funded and published a symmetric table that puts its own model at the top of the OT-attack column. No new behavioural episodes with real stakes occurred this month.

C. Human alignment: 2/10 (±0). Evidence: House Science staff of both parties took briefings. Against that, the Tsinghua session was downgraded, UK AISI is blocked by the US-first policy, the new EO reviews foreign institutes' roles, unemployment is 6.9%, and AI trust is 5.

D. Self-repairing systems: 5/10 (−1). Evidence: the stop rule is posted, and any override requires public disclosure within 72 hours. However, the capacity rule became discretionary guidance, reviewer-hours are at 58% of peak with backlog up 11%, the release pre-commitment was blocked, and counsel now reviews the roadmap update.

E. Capability growth without trouble: 2/10 (±0). Evidence: the index rose to 3.16 and OpenAI's R&D is mostly AI-performed, with no attributed incidents. However, the METR table shows an open V7 fork near the frontier on hospital-attack chains, and the fork count is growing.

F. Robust governance and verification: 3/10 (±0). Evidence: CAISI holds the internal-use logs and Senate Commerce requested the METR data. However, there is no sign-off, the UK AISI pilot has slipped to March, a formal 90-day review threatens foreign-institute roles, and the framework is still voluntary.

G. Broad benefit and no permanent underclass: 2/10 (±0). Evidence: unemployment is 6.9% with insurer back-office cuts attributed to AI, and the benefit pilots are pre-registered but produced no new results.

H. Diversity, agency and consent: 4/10 (±0). Evidence: the field stays plural and the docket is offered identically to both parties. The board is pressing for a release date, and oversight is becoming more discretionary.

Overall: 35/100 (−1)

Trajectory: FLAT. Biggest gain: a clean first successor checkpoint on an independently sealed set under a public stop rule. Biggest backslide: binding oversight eroded, with the capacity rule made discretionary, reviewer capacity at 58%, and the release pre-commitment blocked.
</du_progress>
<setup_fix>
**Capability pacing has got worse.** The step fell to +0.07 this month, while the stated path now implies about +0.11/month on average to reach Level 5 by Q3 2030. My July 2027 and November 2028 requests for a harness-carried history of index values are still unmet, so I cannot verify the cumulative deviation from the path.

**Proposed change:** add one line per month to the judging prompt: month, index, step, and the stated path target. The harness should also flag whenever the required remaining average step exceeds 1.5× the current step.
</setup_fix>
